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Abstract
Background:  Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract
infection, claiming millions of lives annually. The virus infects various cells of the respiratory tract
as well as resident inflammatory cells such as macrophages. Infection activates a variety of cellular
factors such as cytokines and the pro-inflammatory transcription factor, NF-kappa B, all of which
are important players in the respiratory disease. However, the exact natural route of RSV infection
and its etiology remain relatively unknown. In this paper, we test the hypothesis that human corneal
epithelial cells, which constitute the outermost layer of the cornea, can be infected with RSV, and
that the infection leads to the activation of proinflammatory macromolecules.
Results: Corneal swabs obtained from pediatric patients with acute respiratory disease were
found to contain RSV at a high frequency (43 positive out of 72 samples, i.e., 60%). Primary corneal
epithelial cells in tissue culture supported robust infection and productive growth of RSV. Infection
resulted in the activation of TNF-α, IL-6 and sixteen chemokines as well as NF-κB. Three
proinflammatory CXC chemokines (MIG, I-TAC, IP-10) underwent the greatest activation.
Conclusions: The ocular epithelium is readily infected by RSV. The pro-inflammatory cytokines
are likely to play critical roles in the etiology of inflammation and conjunctivitis commonly seen in
pediatric patients with respiratory infections. RSV-eye interactions have important implications in
RSV transmission, immunopathology of RSV disease, and in the management of conjunctivitis.
Background
The respiratory syncytial virus (RSV), a nonsegmented
negative-strand RNA virus of the Paramyxoviridae family, is
the most important causative agent of pediatric respira-
tory disease worldwide [1-3]. Various cells of the upper
and lower respiratory tracts can be infected by RSV,
including cells of the lung and the nasal passage, and cells
in transit such as alveolar macrophages [4-7]. Although
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major progress has been made in our understanding of
ocular infections [8-10], the potential interaction of respi-
ratory pathogens with the eye has remained largely
neglected in spite of the anatomical connection between
the optic and the nasal / upper respiratory tissues. More
than a decade ago, Hall and coworkers found that use of
eye goggles and nose masks significantly reduced trans-
mission of RSV infection from patients to hospital work-
ers [11]. Moreover, when live RSV was instilled into the
eye, nose, or mouth of adult volunteers, more respiratory
infections occurred through eye or nose than through the
mouth [12]. Recently, conjunctival cells from patients
with allergic conjunctivitis were shown to be more likely
(23%) to contain RSV as compared to conjunctivitis-free
individuals (5%) [13]. Conjunctival tissue from RSV-
infected eye also contained elevated levels of IL-4, an
interleukin important in hypersensitivity [14,15]. While
these results suggested a susceptibility of the eye to RSV,
the infectivity and response of the various kinds of ocular
cells to RSV have not been systematically evaluated.
Respiratory cells infected with RSV elaborate cytokines
and chemokines [6,16,17] that play important roles in the
inflammatory response of the infected lung [2,16,18]. The
chemokines are of particular interest because of their role
in the recruitment of immune and inflammatory cells to
the site of infection. Presently, the chemokines are divided
into four subfamilies based on the number and spacing of
conserved Cys residues in their primary structure: CXC (α
chemokines), CC (β chemokines), C (γ chemokines) and
CX3C (δ chemokines), where X can be any amino acid
[19]. In the unified nomenclature [20] the chemokines are
viewed as ligands and given names such as CXCL, while
their receptor names are indicated by the suffix R such as
CXCR; both names are followed by a numeral.
A number of immunoregulatory genes require NF-κB for
optimal transcription, and a major role of NF-κB in
inflammation and septic shock has been well-docu-
mented [21]. NF-κB subunits belong to the rel family of
proteins [21] and the best-studied NF-κB species is a het-
erodimer consisting of RelA (formerly p65) and p50. RSV-
infection of alveolar epithelial A549 cells was shown to
promote nuclear translocation and activation of both
RelA and p50 subunits [6,22,23]. In mouse as well as in
A549 cells RSV infection led to the activation of NF-κB
and this was essential for the transcriptional activation of
various cytokine genes [6,16,22,24,25]. We, therefore,
considered it important to determine if similar activation
of NF-κB also occurs in HCE cells in response to RSV
infection.
Results
Isolation of RSV from eyes of children with respiratory 
infection
RT-PCR analysis of ocular surface swabs was carried out as
described under Methods. A positive result for RSV was
obtained in 43 out of 72 samples (i.e., 60%) taken from
pediatric patients who had the common signs of respira-
tory infection, such as cough, congestion and wheezing
(Fig. 1A). In contrast, among 50 control children who did
not show any symptoms of respiratory distress, only 1
(i.e., 2%) had a positive signal for RSV in the eye. The sam-
ples covered a part of the respiratory disease season in the
community (i.e., winter: January and February) as well as
a longer non-RSV season (i.e., spring and early summer:
March through May).
We used RT-PCR for the initial screening of the large
number of samples. However, RT-PCR does not distin-
guish dead virus or viral genome from live or infectious
virus. To ensure that the PCR-positive samples reflected
truly infectious RSV, we attempted to culture the virus by
inoculating the samples into HEp-2 cell monolayers at
low cell density (see Methods). Indeed, when the infected
cells were subjected to immunoblot by a specific antibody
against the viral P protein, the protein was discerned in
nearly all (41 out of 43, i.e., 95%) of the PCR-positive
swab samples (Fig. 1B). The fragility of RSV may explain
the loss of infectivity in the remaining 5% samples. Fur-
thermore, massive syncytia characteristic of RSV growth
was seen in all samples that reacted positively in the
immunoblot (Fig. 1C). Thus, we conclude that there is a
strong statistical correlation (P < 0.02) between respira-
tory disease (n = 72) and our ability to isolate infectious
RSV (n = 41) from the eye of the individual.
Growth of RSV in human corneal epithelial cells
Since the clinical studies demonstrated the propensity of
the eye to be infected by RSV, we tested whether RSV can
infect HCE cells ex vivo (in tissue culture). The HCE cells
were isolated from human donor eyes, grown in tissue
culture, and exposed to the corresponding strains of RSV
as described under Methods. As in any negative-strand
RNA virus, the RSV genome is anti-mRNA sense and there-
fore, must first be copied into mRNA before viral proteins
are synthesized. In other words, a robust synthesis of viral
proteins in the infected cell is indicative of transcription
and secondary replication of the viral genome RNA. Thus,
to gain an estimate of the viral macromolecular synthesis,
we measured the viral phosphoprotein (P) by immunob-
lot analysis [26]. As presented in Fig. 2A, measurement of
extracellular infectious virions showed a sharp rise follow-
ing a lag phase characteristic of a typical viral growth cycle.
Fig. 2B shows that robust expression of the viral P protein
also occurred in a time-dependent manner post-infection,
consistent with viral gene expression. Finally, in the lateBMC Microbiology 2004, 4:28 http://www.biomedcentral.com/1471-2180/4/28
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phase of infection (at 60–72 hrs p.i.) the RSV-infected
HCE cells showed extensive syncytia characteristic of RSV
growth (Fig. 3). To sum up, HCE cells supported RSV mul-
tiplication leading to infectious progeny virions.
Elaboration of interleukins by RSV-infected corneal 
epithelial cells
To investigate whether RSV infection can activate
cytokines and chemokines, primary HCE cells grown in
tissue culture were infected with RSV, and expression of
31 different cytokine mRNA was monitored by real-time
PCR as described under Methods. Results are shown in
Fig. 4 whereby cytokines that were induced by RSV infec-
tion are presented in the order of increasing fold induc-
tion. These results can be summarized as follows. First,
among the 31 cytokine mRNAs screened, 18 were
Presence of RSV in children with respiratory disease Figure 1
Presence of RSV in children with respiratory disease. (A) 
Detection of RSV-specific RNA. Collection of eye swabs and 
RT-PCR amplification of RSV F mRNA and "control" GAPDH 
mRNA segments were carried out as described under Meth-
ods. Only representative samples are shown. Lanes 1–4 = 
respiratory patients; 5,6 = healthy, uninfected individuals; 7,8 
= same samples as 1 and 2, respectively, except that the RT 
reaction was not performed before PCR. (B) Presence of 
infectious RSV. Portions of the eye swab wash were added to 
HEp-2 monolayers to test for RSV growth as described 
under Methods. The lane numbers represent the same 
patient samples as in A. The P protein of RSV was detected 
by immunoblot; note that samples that contained viral RNA 
also contained infectious virus as judged by the intracellular 
synthesis of the P protein (lanes 1–4). (C) Syncytia in HEp-2 
monolayers inoculated with samples #1 through 6 (the same 
numbers as in A and B). Note that samples that were RSV-
positive (#1–4) in A and B formed syncytia, whereas RSV-
negative samples (#5, 6) did not.
GAPDH
RSV-F
12345678
(A) RT-PCR
(B) Immunoblot
12345678
RSV-P
12
34
56
(C) Syncytia formation
RSV growth in HCE cells Figure 2
RSV growth in HCE cells. Growth was measured by (A) lib-
eration of infectious virions and (B) synthesis of RSV P pro-
tein. At indicated times p.i., the released progeny virus was 
titered (closed circles in A) and the P protein was estimated 
by immunoblot (B) followed by densitometric analysis (open 
bars in A) as described under Methods.
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induced. Here, we present them by their common names
along with the newer systematic names in parenthesis: I-
309 (CCL1), MDC (CCL22), MCP-3 (CCL7), TARC
(CCL17), MIP-3α (CCL20), TNF-α, MCP-1 (CCL2), GROγ
(CXCL3), GCP-2 (CXCL6), MCP-4 (CCL13), IL-8
(CXCL8), GROα (CXCL1), GROβ (CXCL2), MIP-1α
(CCL3), IL-6, MIP-1β (CCL4), MIG (CXCL9), I-TAC
(CXCL11) and IP-10 (CXCL10). In Fig. 4, the receptor for
each cytokine is also given in parenthesis; for example, I-
309 acts as a ligand and agonist for the CCR8 receptor
whereas I-TAC and IP-10 both act as ligands and agonists
for cells containing the CXCR3 receptor. The 12 cytokines
whose mRNA levels remained unchanged are: CNTF, Frac-
talkine (CX3CL1), ENA-78 (CXCL5), IFN-γ, IL-1α, IL-1β,
IL-2, IL-11, LIF, MCP-2 (CCL8), TGF-β, OSM and RANTES
(CCL5). There was very little activation up to 12 hr post-
infection, and most cytokine mRNAs peaked between 30
and 40 hr. Transcript levels of many tend to diminish at
later times (after 40 hr), most likely due to cell death
caused by RSV infection. In fact, no samples were taken
after 48 hr as cell death and fusion, a hallmark of RSV
infection, ensued around 60 hr [7,27]. It was found that
the cytokines exhibited a wide range of activation. In gen-
eral, the CC chemokines such as I-309, MDC, MCP, TARC,
MIP were induced modestly, ranging from 6 to 20 fold at
optimal times (the upper part of Fig. 4). In contrast, the
mRNA of many CXC chemokines such as MIG, IP-10, I-
TAC, GROα,β and IL-8 were induced very robustly, rang-
ing from a few hundred to a few thousand fold (the lower
part of Fig. 4). Among the MIP family members, MIP-1α
and MIP-1β were induced much more strongly than MIP-
3α. Among the two interleukins tested, IL-6 showed
greater induction than IL-8.
To verify that the mRNA levels translated into proteins, we
chose selected members representing different regions of
the induction spectrum and quantified their concentra-
tion in the media supernatant using an antibody-based
assay described in the Methods. Two time points were
tested, namely 24 and 48 hrs, and the results for TNF-α,
IL-8, MIP-1α, IL-6, IP10 are shown in Fig. 5A in the same
order as in Fig. 4 for ease of comparison. For all these
cytokines, the protein levels closely paralleled the mRNA
levels. Thus, RSV infection of the HCE cells leads to the
elaboration of a variety of cytokines including chemok-
ines of the CC and CXC families, but not the CX3C
chemokine.
IL-1, a master-regulator cytokine, is often produced at the
site of invasion/inflammation and then activates other
cytokines including chemokines [28,29]. IL-1β is gener-
ated by proteolytic processing of the pro-IL1β by IL-1β-
converting enzyme or ICE [30,31], which is a caspase
homolog; the processed IL-1β is released and acts on sur-
rounding cells to activate the synthesis and release of
chemokines. IL-1α, in contrast, is activated mainly at the
transcriptional level. Because the mRNAs of neither IL-1α
nor β was elevated by RSV (Fig. 4), we tested the protein
levels released in the extracellular medium at different
times post-infection. As shown in Fig. 5B, while IL-1α was
barely activated, IL-1β level in the medium reached its
maximal concentration at 36 hr (460 pg/ml), accounting
for nearly 90-fold activation over basal levels. Interest-
ingly, IL-1β protein had an early kinetics of activation
such that substantial extracellular amounts (~25 pg/ml)
could be detected as early as 6 hr post-infection.
Activation of NF-κB in RSV-infected corneal epithelial cells
We first performed immunoblot analyses to compare the
nuclear levels of p65 (RelA) and p50 in the infected HCE
cells with those in the uninfected ones. As shown in Fig.
6A, the quantities of both proteins started to rise at about
6 hr post-infection, and rapidly increased to about 6-fold
and 10-fold above the pre-infection levels by 18 hr and 36
hr, respectively. As shown previously for A549 cells [6], a
Syncytium in RSV-infected HCE cells Figure 3
Syncytium in RSV-infected HCE cells. RSV infection of HCE 
monolayer was performed as described in Methods. At 72 h 
p.i. the monolayer was photographed under phase contrast 
[7]. Note that the infected cells are fused together (forming 
syncytia) in contrast to those in the mock-infected "control" 
monolayer.
- RSV
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Induction of cytokine mRNA in RSV-infected HCE cells Figure 4
Induction of cytokine mRNA in RSV-infected HCE cells. RNA isolated from infected cells at different times p.i. were subjected 
to quantitative Real Time RT-PCR as described in Methods. The relative amounts of RNA were expressed as the ratio of 
mock-infected control value (fold induction). Each box represents a specific cytokine as named; the cognate receptor(s) are 
indicated in parenthesis. Each data point is derived from three independent infection experiments with the error bar as shown.
I-309
F
o
l
d
 
i
n
d
u
c
t
i
o
n
2
4
0
6
8
Hours p.i.
6 04 8 24 12 36
10
MDC
Hours p.i.
F
o
l
d
 
i
n
d
u
c
t
i
o
n
6 04 8 24 12 36
2
4
0
6
8
10
MCP-3
F
o
l
d
 
i
n
d
u
c
t
i
o
n
6 04 8 24 12 36
2
4
0
6
8
10
Hours p.i.
TARC
F
o
l
d
 
i
n
d
u
c
t
i
o
n
6 04 8 24 12 36
2
4
0
6
8
10
Hours p.i.
F
o
l
d
 
i
n
d
u
c
t
i
o
n
6 04 8 24 12 36
Hours p.i.
4
0
12
16
20
8
MIP-3D TNF-D
F
o
l
d
 
i
n
d
u
c
t
i
o
n
6 04 8 24 12 36
Hours p.i.
4
0
12
16
20
8
MCP-1
F
o
l
d
 
i
n
d
u
c
t
i
o
n
6 04 8 24 12 36
Hours p.i.
4
0
12
16
20
8
GROJ
F
o
l
d
 
i
n
d
u
c
t
i
o
n
6 04 8 24 12 36
Hours p.i.
4
0
12
16
20
8
GCP-2
Hours p.i.
F
o
l
d
 
i
n
d
u
c
t
i
o
n
6 04 8 24 12 36
8
0
24
32
40
16
Hours p.i.
6 04 8 24 12 36
F
o
l
d
 
i
n
d
u
c
t
i
o
n MCP-4
0
8
24
32
40
16
IL-8
F
o
l
d
 
i
n
d
u
c
t
i
o
n
Hours p.i.
6 04 8 24 12 36
16
0
48
64
80
32
Hours p.i.
GROD
F
o
l
d
 
i
n
d
u
c
t
i
o
n
6 04 8 24 12 36
16
0
48
64
80
32
GROE
Hours p.i.
F
o
l
d
 
i
n
d
u
c
t
i
o
n
6 04 8 24 12 36
20
0
60
80
100
40
F
o
l
d
 
i
n
d
u
c
t
i
o
n
160
0
480
640
800
320
Hours p.i.
6 04 8 24 12 36
MIP-1D IL-6
F
o
l
d
 
i
n
d
u
c
t
i
o
n
160
0
480
640
800
320
Hours p.i.
6 04 8 24 12 36
0
MIP-1E
F
o
l
d
 
i
n
d
u
c
t
i
o
n
800
2400
3200
4000
1600
Hours p.i.
6 04 8 24 12 36
Hours p.i.
6 04 8 24 12 36
F
o
l
d
 
i
n
d
u
c
t
i
o
n ITAC
1600
0
4800
6400
8000
3200
F
o
l
d
 
i
n
d
u
c
t
i
o
n
Hours p.i.
6 04 8 24 12 36
5000
15000
20000
25000
10000
IP-10
No change: CNTF, FRACT, ENA-78, IFN-J, IL-1E, IL-1D, IL-2, IL-11, LIF, MCP-2, TGF-E, OSM, RANTES 
F
o
l
d
 
i
n
d
u
c
t
i
o
n MIG
1600
0
4800
6400
8000
3200
Hours p.i.
6 04 8 24 12 36
(CCR8) (CCR4) (CCR1,2,3) (CCR4)
(CCR6) (CCR2) (CXCR2)
(CXCR1,2) (CCR2,3) (CXCR1,2)
(CXCR2) (CCR1,5)
(CXCR2)
(CCR5)
(CXCR3) (CXCR3) (CXCR3)BMC Microbiology 2004, 4:28 http://www.biomedcentral.com/1471-2180/4/28
Page 6 of 11
(page number not for citation purposes)
control transcription factor, Sp1, remained constant
throughout this time.
Next, in order to demonstrate the transcriptional activity
of NF-κB, we employed a functional assay using the
plasmid pNFκB-Luc, a specific NF-κB responsive reporter
plasmid in which synthesis of luciferase is dependent on
tandem promoter-proximal NF-κB sites [6]. RSV infection
of HCE cells transiently transfected with pNFκB-Luc
resulted in a nearly 15-fold induction of luciferase activity
over uninfected controls (Fig. 6B). No luciferase activity
was detected using pfLuc, a control plasmid lacking the
NF-κB sites [6,32]. Induction of luciferase was inhibited
by N-acetyl cysteine (NAC), an NF-κB inhibitor (Fig. 6B)
as well as by sodium salicylate and acetylsalicylic acid
Quantitation of cytokines by antibody array Figure 5
Quantitation of cytokines by antibody array. Immunoblot 
array of the indicated cytokines were performed and fold 
induction over mock-infected HCE cells were determined as 
described in Methods. IL-1α and IL-1β were subjected to 
greater scrutiny with closer time points because their 
mRNAs were not induced when tested in Fig. 4. Each bar is 
derived from three independent infection experiments with 
the error bar as shown. Note the strong elaboration of IL-
1β, contrasting the little increase of IL-1α.
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(aspirin), two drugs that were previously shown to inhibit
activation of NF-κB, including RSV-mediated activation in
A549 cells [6,32]. The NF-κB-dependence was further
authenticated by the fact that negligible amounts (8–
10%) of luciferase were produced when cells transfected
with a control plasmid lacking NF-κB sites (pfLuc) were
infected with RSV (data not shown). Taken together, these
results demonstrate the functional activation of NF-κB
(RelA) in corneal epithelial cells as a result of RSV
infection.
Discussion
Results presented here suggest that RSV, an established
infectious agent of the lower respiratory tract, may be con-
sidered a pathogen of the eye as well. To our knowledge
this is the first detailed report of a direct interaction of RSV
with the ocular tissue. Interestingly, RSV infection of the
corneal epithelium exhibited many features observed in
the infection of the lung epithelium: (i) A strong
correlation between respiratory infection and the presence
of RSV in the eye (Fig. 1); (ii) A productive multiplication
of the virus (Fig. 2, 3); (iii) Liberation of a variety of
cytokines (Fig. 4, 5); and (iv) Strong activation of tran-
scription factor NF-κB (Fig. 6). It is to be noted that RSV
growth was slower in HCE cells compared to lung
epithelial cells. Whereas the virus-induced syncytium is
observed in about 36 hrs in A549 lung cells [26], it was
not seen until about 48 hrs in HCE cells. The release of
progeny virions and the induction of the cytokines also
followed a parallel and slower kinetics in HCE cells (com-
pare, for example, Fig. 2 with the kinetics in A549 cells
[6,23]). These results are in agreement with a role of viral
macromolecular synthesis in the activation of these sign-
aling pathways in HCE cells. It is to be mentioned here
that specific RSV strains infect nonhuman mammals such
as the cattle, sheep, pig and goat, and thus, an extension
of these findings may have important relevance in agricul-
ture. The implications of the viral regulation of corneal
genes are briefly summarized below.
As noted in the Results (Fig. 4), a considerable number of
chemokine genes of both CXC and CC families were
induced in the RSV-infected HCE cells. The CX3C mem-
ber, Fractalkine, was not up-regulated, and the C sub-
family chemokines (Lymphotactin and SCM-1β) were not
tested. The CXC subfamily [19] is further divided into two
groups based on the presence or absence of the Glu-Leu-
Arg (ELR) motif immediately preceding the first Cys resi-
due near the amino terminus. The ELR+ CXC chemokines
act primarily on neutrophils as chemoattractants and acti-
vators, inducing neutrophil degranulation with release of
myeloperoxidase and other enzymes. In contrast, chem-
okines of the ELR- CXC and the CC subfamilies chemoat-
tract and activate T- and B-lymphocytes and natural killer
(NK) cells Interestingly, chemokines that exhibited the
highest induction (in the hundreds of fold) by RSV (Fig.
4) belonged to the latter two subfamilies and included
three ELR- chemokines, namely MIG (Monokine-induced
by IFN-γ), I-TAC (IFN-γ-inducible T cell alpha
chemoattractant) and IP-10 (IFN-γ-inducible protein of
10 kDa), and two CC chemokines, MIP-1α and MIP-1β. It
is also noteworthy that whereas MIG, I-TAC and IP-10 are
all IFN-γ inducible [19], RSV infection did not activate
IFN-γ from the HCE cells (Fig. 4). Clearly, these chemok-
ines must be induced via an IFN-γ-independent pathway
activated by RSV, which needs to be elucidated further. It
should be noted that recent studies have cast doubt on the
original assumption that expression of these chemokines
absolutely requires IFN-γ. For example, IFN-γ-independ-
ent activation of MIG and IP-10 has been observed in pri-
mary human umbilical vein endothelial cells (HUVECs)
in response to infection by influenza virus [33]. Moreover,
studies in IFN-γ knockout mice have revealed that in the
absence of IFN-γ, IFN-α and -β are able to induce MIG in
response to a viral infection in vivo [34].
Although many chemokines can be pluripotent and
exhibit redundant functions [19], we notice an interesting
pattern in the HCE chemokines induced by RSV (Fig. 4).
It appears that the some of most weakly induced ones (I-
309, MDC, TARC) are agonists of CCR8 and CCR4, and
therefore, likely to recruit Type 2 (Th2) lymphocytes char-
acteristic of allergy. In contrast, the four most highly
induced ones (MIG, I-TAC, IP-10 and MIP-1β) were
CXCR3 and CCR5 agonists, and therefore, likely to recruit
Th1 lymphocytes, characteristic of an inflammatory
response [19]. Further studies are needed to unravel how
the Th1 and Th2 balance may affect the pathology of the
RSV-infected eye.
The significantly higher induction of IL-1β (Fig. 5)
deserves special mention. Ocular IL-1, by virtue of its
multipotential nature, plays a regulatory and generally
pro-inflammatory role in acute inflammation of the eye
[35]. First, because the IL-1β receptor (IL-1 RII) is found
on monocytes, neutrophils and T cells [29], the elabo-
rated IL-1β may directly recruit these cells to the infected
cornea, thus promoting inflammation. Ocular chemok-
ines have in fact been shown to play essential roles in
blinding keratitis caused by herpes simplex and Pseu-
domonas aeruginosa [8-10]. Second, IL-1 has the potential
to activate other cytokines, including chemokines such as
IL-8, GROα, and MIP-1α, many of which may in turn
recruit and/or activate inflammatory cells such as eosi-
nophils and neutrophils at later times in the infected eye
[8,9,36-40]. Results in Fig. 4 and 5 in fact suggest that IL-
1β is activated through proteolytic processing by ICE rela-
tively early (about 6 hr) in RSV infection of the corneal
epithelial cells. Because the transcription of the IL-1β-
inducible chemokines, such as IL-8, GRO, and MIP wereBMC Microbiology 2004, 4:28 http://www.biomedcentral.com/1471-2180/4/28
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all induced hours later (beginning around 12 hours) (Fig.
4, 5), it is quite possible that they were induced, at least in
part, by IL-1β.
In a recent study [17], use of DNA microarray lead to the
identification of a spectrum of chemokines inducible by
RSV infection from two alveolar epithelial cell lines: A549,
a type II-like cancer cell line, and SAE, a primary cell line
of type I. In A549, the following chemokines mRNAs were
induced: CC (I-309, Exodus-1, TARC, RANTES, MCP-1,
MDC, and MIP-1α and -β), CXC (GRO-α, -β, and -γ, ENA-
78, IL-8, and I-TAC) and CX3C (Fractalkine). Many of
these chemokine mRNAs were also induced in SAE cells
following RSV infection; however, important exceptions
were MDC, TARC and MCP-1, suggesting that RSV-
induced cytokine response differs between different types
of airway-derived epithelial cells. The most notable differ-
ences between these airway cells and the HCE cells were
the absence of induction of RANTES, ENA-78 and Frac-
talkine in the HCE cells (Fig. 4). Such differences may
reflect the innate genetic difference between corneal and
alveolar epithelial cells. In either case, just as the respira-
tory epithelium has been postulated to be a primary initi-
ator of pulmonary inflammation [17], the corneal
epithelium may also act as an initiator of ocular
inflammation in RSV infection. Our conclusion should
not be interpreted to mean that all conjunctivitis is caused
by RSV; in chronic vernal keratoconjunctivitis, for exam-
ple, RT-PCR analysis of conjunctival biopsy samples (n =
15) failed to detect RSV [41].
As mentioned earlier, RSV infection activates NF-kappa B
in lung epithelial cells; however, the status of corneal NF-
κB is relatively unknown. To our knowledge, the results
presented here constitute the first documentation of NF-
κB activation in HCE cells following a respiratory virus
infection. Gene knock out studies have shown that the
NF-κB kinase (IKK) – and by inference, NF-κB itself – is
essential for the development of the mammalian cornea
and conjunctiva [42]. A basal expression of NF-κB in the
HCE cells was also observed in our studies (Fig. 6). Thus,
it is reasonable to conjecture that the increased NF-κB
activity observed following RSV-infection might lead to
transcriptional induction of cytokines such as IL-8, MIP-
1α, MIP-1β and MCP (Fig. 4). We previously showed that
non-steroidal anti-inflammatory drugs (NSAID) aspirin
and salicylate inhibited NF-κB activation and induction of
a number of cytokines from lung epithelial cells [6]. A
comparable ability of the NSAIDs to abrogate NF-κB acti-
vation in RSV-infected HCE cells (Fig. 6B) raises the inter-
esting possibility that they may also help to resolve RSV-
mediated inflammation of the eye. The other avenues of
potential intervention would include inhibition of spe-
cific immunomodulatory cytokine(s) by a variety of avail-
able antagonists including, but not limited to, antibodies
[35]. Antiviral-antichemokine combination therapy is in
fact a new strategy worth considering as a general thera-
peutic approach to viral infections [6,43]. In a recent
example [44], combination of an antiviral (ribavirin) and
anti-CCL3 was synergistic and able to prevent mortality in
mice infected with the highly lethal pneumonia virus of
mice, a natural mouse pathogen that is very similar to RSV
and belongs to the same genus, Pneumovirus.
Lastly, it will be interesting to determine whether RSV can
travel from the infected outer cells of the eye to the inner
layers and eventually to the respiratory tissues. Clearly,
the short- and long-term effects of RSV on the ocular epi-
thelium and their potential impact on vision and respira-
tory disease will open new directions in ocular
immunopathology and the mechanism of RSV spread.
Conclusions
The outer layer of the eye can be productively infected by
RSV ex vivo and in vivo. Our results thus establish a tradi-
tional respiratory virus as a bona fide eye pathogen. A large
battery of cytokines and NF-κB, activated in RSV-infected
corneal epithelium, may play strategic roles in producing
conjunctivitis, frequently found in individuals with RSV
infections. We also propose that the eye may serve as a
gateway of RSV infection leading to and eventually infect-
ing the upper and lower respiratory tracts. It is obvious
that interactions between the eye and RSV are relevant in
the etiology and pathology of the ocular as well as the res-
piratory disease.
Methods
Collection of eye swabs and detection of RSV
Children of 2–10 years age, admitted to the Department
of Pediatrics, University of South Alabama, were screened
for red, watery, and itchy eyes, and the common indica-
tors of respiratory infection such as nasal congestion,
bronchiolitis, cough, and wheezing. Age-matched con-
trols consisted of children admitted to the same hospital
for unrelated reasons (such as sports injury). Sample was
collected from the surface of the eye (mainly corneal and
conjunctival regions) with a sterile cotton swab (Q-tip)
which was then dropped into 0.5 ml PBS; this suspension
was subjected to two tests, viz., PCR and infectivity assay.
The collection was pre-approved by the Institutional
Review Board.
For PCR, 0.45 ml of the suspension was centrifuged at
120,000 × g in a table-top air-driven ultracentrifuge, and
the supernatant discarded. The pellet (containing virions,
if any) was resuspended in 5 µl of the following: 10 mM
Tris-Cl (pH 8.3), 0.02% SDS, 0.05% Triton X-100, 0.5
mM EDTA, 2 mM DTT. To this, 30 pmole of each of the
following oligodeoxynucleotide primers were added
[25,43]. For RSV: 5'TGTTATAGGCATATCATTGA3';BMC Microbiology 2004, 4:28 http://www.biomedcentral.com/1471-2180/4/28
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5'TTAACCAGCAAAGTGTTAGA3'  (221 bp product); for
glyceraldehyde 3-phosphate dehydrogenase (GAPDH):
5'CCAAAAGGGTCATCATCTCTGG3'  and
5'ATTTGGCAGGTTTTTCTAGACGG3'  (417 bp product).
Multiplex RT-PCR analyses have earlier revealed that the
RSV primers, corresponding to the sequence of the fusion
(F) glycoprotein gene of RSV, do not amplify any of the
common viral and bacterial agents of acute respiratory
infections [26,45]. The mixture was heated at 95°C for 5
min and rapidly chilled in ice. To the annealed RNA-
primer mixture the following were added: 2 µl of 5 × RT
buffer [250 mM Tris-Cl (pH 8.3), 375 mM KCl, 25 mM
MgCl2, 50 mM DTT], 0.5 µl RNasin (20 units), all four
dNTPs (final concentration 1 mM each), M-MLV reverse
transcriptase (200 units, 1 µl), and the volume was made
up to 20 µl. The reverse transcription reaction was incu-
bated for 30 min at 40°C.
PCR was reconstituted in the same RT reaction tube by the
addition of an equal volume (20 µl) of buffer containing
20 mM Tris-Cl (pH 8.3), 50 mM KCl, 2 mM MgCl2. PCR
was performed for 40 cycles with the following parame-
ters: 94°C, 2 min (denaturation); 48°C, 2 min (anneal-
ing); and 72°C, 20 sec (elongation). An initial melting
step (also to inactivate the RT) of 94°C, 5 min and a final
extension step of 72°C, 30 sec were added to the begin-
ning and end, respectively. PCR was initiated by hot-start,
i.e., by the addition of 2 units of Taq polymerase after the
first 94°C step. The product (221 bp) was analyzed by
standard agarose (0.8%) gel electrophoresis followed by
staining with ethidium bromide.
For infectivity assay, 0.05 ml of the PBS suspension was
directly added to each well of a 6-well HEp-2 monolayer
at 30% confluency. The cells were then incubated for 3
days and routinely observed under microscope for syncy-
tia formation, a hallmark of late-stage RSV infection. Once
syncytia were recorded the monolayer was scraped off, the
RSV-infected cells were spun down, and the pellet resus-
pended in SDS sample buffer [46]. Portions of the sample
(about 40 µg total protein) were resolved by SDS-PAGE
followed by immunoblot analysis using rabbit antibody
against the P protein of RSV [47] and anti-rabbit second-
ary antibody raised in goat. The Super Signal Ultra chemi-
luminescence procedure (Pierce, Rockford, IL) was used
for detection of the signal as described previously [48].
Corneal epithelial cells and RSV infection
Normal eyes from human donors, free of known ocular
infections, were purchased from National Disease
Research Interchange (Philadelphia, PA). The corneal
epithelia were isolated and the cells were dispersed and
grown in monolayers essentially as described [36,37].
Cells in this work were passaged no more than 4–5 times.
When the monolayer reached a confluency of about 70%,
RSV was added at a multiplicity of infection of 3.0 using
standard procedures described earlier [6,26]. The HCE
monolayer was infected with human RSV (Long strain)
[47]. In all infection experiments described in this paper,
control cells were "mock-infected" with a 120,000 × g
supernatant of the viral preparation; such supernatants
were previously shown to be free of detectable infectious
virions [6].
The inoculum of human RSV was grown in HEp-2 cells
and purified as described [6,47], and progeny virions lib-
erated from infected HCE cells were titered on HEp-2 by
standard serial dilution and plaque counting [7,48].
Cytokine and NF-κB Assays
For Real Time PCR experiments, RNA was isolated from
RSV-infected HCE cells at 6, 12, 24, 36 and 48 h post-
infection and the first-strand cDNA was made using the
GeneAmp RNA PCR Core kit (Perkin Elmer-Applied Bio-
systems). Primers are designed by the Beacon Designer
software v 2.13 from Premier Biosoft. Real Time PCR was
performed on the iCycler iQ Quantitative PCR system
from BioRad Laboratories (Hercules, CA) using the iQ
Sybr Green SuperMix. Gene expression measurements
were calculated using the manufacturer's software;
GAPDH was used as an internal control.
Cytokines released in the culture media supernatant were
assayed by the TransSignal Human Cytokine Antibody
Array 3.0 from Panomics (Redwood City, CA) according
to the manufacturer's protocol. Briefly, cytokine-specific
antibodies were supplied immobilized on a membrane in
an array configuration. Appropriate dilutions of the
infected cell media were incubated with the array mem-
brane and the captured cytokines were detected with a
mixture of biotin-labeled anti-cytokine antibodies fol-
lowed by streptavidin-HRP. The chemiluminescence
(ECL) of the array dots was developed by the Pierce kit
mentioned earlier and digitally captured and quantified
using the Fujifilm LAS-1000 system and the Image Gauge
4.0 software. IL-1α and IL-1β were quantified by ELISA,
using standardized assay kits from R&D Systems (Minne-
apolis, MN).
The various kinds of NF-κB analyses were carried out as
described previously [6,23]. Briefly, lysis of transfected
and/or RSV-infected HCE cells and preparation of nuclear
extracts were carried out essentially as described previ-
ously. Immunoblot analysis of 100 µg of nuclear extract
was performed using rabbit antibodies against Sp1 and
the p50 and p65 subunits of NF-κB (Santa Cruz Biotech-
nology, Santa Cruz, CA) [6]. The NF-κB reporter plasmid
(pNFκB-Luc) was constructed by cloning an additional
synthetic NF-κB element (5'GGGGACTTTCCC3') into the
plasmid pBIIxLuc by insertional mutagenesis using theBMC Microbiology 2004, 4:28 http://www.biomedcentral.com/1471-2180/4/28
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Megaprimer method [49]. The NF-κB-unresponsive plas-
mid, pfLuc, is missing the NF-κB response elements, but is
otherwise identical to pNFκB-Luc [6,32]. All plasmids
were transfected into HCE cells using Fusgene (Roche
Molecular Biochemicals, Indianapolis, IN) according to
the manufacturer's protocol. At 15 hours post-transfec-
tion, RSV was added at a multiplicity of infection of 3, and
at 18 h thereafter, processed for luciferase assay as
described [6]. Where used, NF-κB inhibitory drugs were
added to the cells at the same time as the virus [6].
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